Back | Next |
home / stock / poai / poai message board
Subject | By | Source | When |
---|---|---|---|
What a POFS! Had a chance to get | Distantpulse | investorshub | 04/14/2023 6:21:21 PM |
Dropped equally as fast | jchords | investorshub | 04/14/2023 5:15:41 PM |
Good call | jchords | investorshub | 04/14/2023 2:18:09 PM |
going in MONSTA | knrorrel | investorshub | 04/14/2023 1:31:24 PM |
This update is from yesterday morning and explains | BubbaCheese | investorshub | 04/14/2023 1:20:19 PM |
WOW! Awesome $$$$$$$$$$$$ WOOHOOOOOO | weedtrader420 | investorshub | 04/14/2023 11:12:34 AM |
Looking good | tw0122 | investorshub | 04/14/2023 11:10:02 AM |
WOOHOOOOOO WOOHOOOOOO $POAI$ | weedtrader420 | investorshub | 04/14/2023 10:40:43 AM |
znewcar1: $POAI 77% v13,2M c.49 f79,4M H.49 ML.25 LL.21 gapNhodl.30 | znewcar1 | investorshangout | 04/13/2023 9:05:37 PM |
Looks very good. Still has a lot | knrorrel | investorshub | 04/13/2023 7:55:17 PM |
Could be setting up for the next cheap | trendzone | investorshub | 04/13/2023 7:52:44 PM |
boooming starts on new AI hype | knrorrel | investorshub | 04/13/2023 7:48:17 PM |
$POAI$ | weedtrader420 | investorshub | 04/13/2023 5:22:22 PM |
$POAI already did a reverse stock split. This | 77Port | investorshub | 03/14/2023 9:27:42 PM |
Well, looks like a R/S coming soon. These | Distantpulse | investorshub | 03/09/2023 3:10:35 PM |
I believe I mistook a filing I saw | urge2surge | investorshub | 02/22/2023 2:01:20 AM |
Do you know how to read the filing | MatrixMoney | investorshub | 02/22/2023 1:40:40 AM |
Under ihub post forum news feature. Looks like | urge2surge | investorshub | 02/21/2023 6:30:52 PM |
Where did you get this info? | Distantpulse | investorshub | 02/21/2023 6:19:02 PM |
13G sale was filed by insider. Everything | urge2surge | investorshub | 02/21/2023 6:08:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
Predictive Oncology Inc. Website:
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a...
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value annual US GPCR market at nearly $3.5 billion in 2022, growing more than 5% annu...
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the availability of its unique 3D cell culture model to advance cancer drug discovery and enable future drug development. More closely mimicking human tissue architecture than traditional 2D a...